«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

28卷

期数:

2022年04期

页码:

409-413

栏目:

临床医学

出版日期:

2022-07-20

文章信息/Info

Title:

Effect of dexmedetomidine on inflammation and prognosis in elderly patients with sepsis requiring mechanical ventilation

文章编号:

1006-8147（2022）04-0409-05

作者:

于乐昌¹; 杨立恒²; 张蔷¹

（1.天津医科大学总医院保健医疗部，天津300052；2.天津市胸科医院呼吸科，天津 300222）

Author(s):

YU Le-chang¹; YANG Li-heng²; ZHANG Qiang¹

（1.Department of Health Care，The General Hospital，Tianjin Medical University，Tianjin 300052，China；2.Department of Respiratory，Tianjin Chest Hospital，Tianjin 300222，China）

关键词:

右美托咪定; 机械通气; 老年人; 脓毒症; 炎症

Keywords:

dexmedetomidine; mechanical ventilation; elderly;  sepsis; inflammatory response

分类号:

R453

DOI:

-

文献标志码:

A

摘要:

目的：探讨右美托咪定（Dex）对老年脓毒症机械通气患者炎症和预后的影响。方法：回顾性分析2015年9月—2019年8月天津医科大学总医院老年重症监护室收治的64例脓毒症需机械通气治疗患者的临床资料，分为常规治疗+Dex组（Dex组，36例）和常规治疗组（28例）。收集两组基础信息，包括年龄、性别、入住ICU时急性生理学及慢性健康状况评分系统评分（APACHEⅡ评分）和序贯器官衰竭评分（SOFA评分）、机械通气时间、入住ICU时间、基础病、感染部位；治疗前和治疗后第3、7天外周血T细胞亚群比例（CD4+T、CD8+T、CD4+T/CD8+T）及各自凋亡率（CD4+T、CD8+T），细胞因子[白细胞介素（IL）-6、IL-10、肿瘤坏死因子（TNF）-α）]水平；计算入住ICU期间多器官功能障碍综合征（MODS）发生率和病死率，并对两组入住ICU期间28 d存活状况进行生存分析。结果：两组性别、年龄、APACHE Ⅱ评分、SOFA评分、机械通气时间、ICU住院时间、基础病、感染部位差异均无统计学意义（均P＞0.05）。两组治疗后第7天CD4+T细胞比例、CD4+/CD8+较治疗前升高，且Dex组高于常规治疗组，而CD4+T细胞凋亡率较治疗前降低，且Dex组低于常规治疗组（t=2.670、 1.960、-1.984，均P＜0.05）。两组TNF-α、IL-6水平总体呈下降趋势，第7天TNF-α、IL-6水平较治疗前降低明显，且Dex组低于常规治疗组（t=-2.159、-2.382，均P＜0.05）。两组入住ICU期间MODS发生率（χ2=0.638）和病死率（χ2=0.145）差异均无统计学意义（均P＞0.05）；然而Dex组28 d生存率高于常规治疗组（Log-rank=4.099，P＜0.05）。结论：Dex可能调节老年脓毒症机械通气患者T淋巴细胞亚群比例，降低炎症指标水平，提高入住ICU期间28 d生存率，从而改善预后。

Abstract:

Objective： To investigate the effect of dexmedetomidine（Dex） on inflammation and prognosis in elderly patients with sepsis requiring mechanical ventilation. Methods：The clinical data of 64 eligible patients with sepsis requiring mechanical ventilation in the Elderly ICU of the General Hospital of Tianjin Medical University from September 2015 to August 2019 were retrospectively reviewed. They were divided into routine treatment+Dex group（Dex group，36 cases）and routine treatment group（28 cases）. The collected information included demographic characteristics，acute physiology and chronic health evaluation（APACHE Ⅱscore）and sequential organ failure assessment（SOFA score）at admission of ICU，mechanical ventilation time，ICU length of stay，medical comorbidities，site of infection，proportion of T cell subsets（CD4+T，CD8+T），ratio of CD4+ to CD8+，apoptotic rates（CD4+T，CD8+T），cytokine levels（IL-6，IL-10，and TNF-α）before treatment and on the 3rd and 7th days after treatment. The occurrence and mortality of multiple organ dysfunction syndrome（MODS）during ICU admission were calculated，and the 28-day survival status of the two groups during the ICU stay was analyzed. Results：There were no significant differences between the two groups with respect to age，sex，APACHE Ⅱ score，SOFA score，mechanical ventilation time，ICU length of stay，underlying disease，site of infection（all P>0.05）. The proportion of CD4+ T cells and CD4+/CD8+ on the 7th day after treatment increased compared with that before treatment，and the Dex group was higher than the control group，while the apoptotic rate of CD4+ T cells decreased compared with that before treatment，and the Dex group was lower than the control group（t=2.670，1.960，-1.984，all P＜0.05）. In general，the levels of TNF-α and IL-6 in the two groups showed a downward trend，TNF-α and IL-6 levels on the 7th day after treatment decreased significantly compared with those before treatment，and the Dex group was lower than the control group（t=2.159，-2.382，both P＜0.05）. The incidence of MODS（χ2=0.638）and mortality（χ2=0.145）were not statistically significant during the ICU stay（both P>0.05）. However，the 28-day survival rate of patients in the Dex group was higher than that in the control group （Log-rank=4.099，P<0.05）. Conclusion：Dex may adjust the proportion of T lymphocyte subsets in elderly patients with sepsis requiring mechanical ventilation，reduce the level of inflammatory indicators，and increase the 28-day survival rate during the ICU stay，thereby improve the prognosis.

参考文献/References:

[1] SINGER M，DEUTSEHMAN C S，SEYMOUR C W，et aｌ.The Third international consensus definitions for sepsis and septic shock （Sepsis-3）[J]. JAMA，2016，315（8）：801-810．
[2] MARTIN G S. Sepsis，severe sepsis and septic shock：changes in incidence，pathogens and outcomes[J].Expert Rev Anti Infect Ther，2012，10（6）：701-706.
[3] HOTCHKISS R S，MONNERET G，PAYEN D．Immunosuppression in sepsis：a novel understanding of the disorder and a new therapeutic approach [J]. Lancet Infect Dis，2013，13（3）：260-268.
[4] NOMELLINI V，GOITTEZ C R，GAMELLI R L，et aｌ.Aging and animal models of systemic insult：trauma，bum，and sepsis[J]．Shock，2008，31（1）：11-20．
[5] KUNISAWA T. Dexmedetomidine hydrochloride as a long-term sedative [J].Ther Clin Risk Manag，2011，7：291-299.
[6] DING J，CHEN Y W，GAO Y. Effect of propofol，midazolam and dexmedetomidine on ICU patients with sepsis and on arterial blood gas[J]. Exp Ther Med，2019，18（6）：4340-4346.
[7] TANIGUCHI T，KURITA A，KOBAYASHI K，et aｌ. Dose-and time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin -induced shock in rats[J]. J Anesth，2008，2（3）：221-228.
[8] SUN Y B，ZHAO H L，MU D L，et aｌ. Dexmedetomidine inhibits astrocyte pyroptosis and subsequently protects the brain in in vitro and in vivo models of sepsis[J]. Cell Death Dis，2019，10（3）：167.
[9] MEI B，LI J，ZUO Z Y. Dexmedetomidine attenuates sepsis -associated inflammation and encephalopathy via central α2A adrenoceptor[J]. Brain Behav Immun，2021，91：296-314.
[10] WANG R H，XIE Y X，QIU J W，et aｌ. The effects of dexmedetomidine in a rat model of sepsis-induced lung injury are mediated through the adenosine monophosphate-activated protein kinase （AMPK）/silent information regulator 1（SIRT1）pathway[J]. Med Sci Monit，2020，26：e919213.
[11] PANDHARIPANDE P P，SANDERS R D，GIRARD T D，et aｌ. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis：an a priori-designed analysis of the MENDS randomized controlled trial [J]. Crit Care，2010，14（2）：R38.
[12] RHODES A，EVANS L E，ALHAZZANI W J，et aｌ．Surviving sepsis campaign：international guidelines for management of sepsis and septic shock：2016[J].Intensive Care Med，2017，43（3）：304-377.
[13] ELY E W，TRUMAN B，SHINTANI A，et aｌ. Monitoring sedation status over time in ICU patients：reliability and validity of the Richmond Agitation-Sedation Scale（RASS）[J]. JAMA，2003，289（22）：2983-2991.
[14] BARR J，FRASER G L，PUNTILLOLLO K，et aｌ. Clinical practice guidelines for the management of pain，agitation，and delirium in adult patients in the intensive care unit[J].Crit Care Med，2013，41（1）：263-306.
[15] HUGHES C G，PANDHARIPANDE P P. Review articles：the effects of perioperative and intensive care unit sedation on brain organ dysfunction [J].Anesth Analg，2011，112（5）：1212-1217.
[16] LIU Z G，WANG Y Q，NING Q Q，et aｌ. The role of spleen in the treatment of experimental lipopolysaccharide-induced sepsis with dexmedetomidine [J]. SpringerPlus，2015，4：800.
[17] BONAZ B，PICP C，SINNIGER V，et aｌ. Vagus nerve stimulation：from epilepsy to the cholinergic anti-inflammatory pathway [J]. Neurogastroenterol Motil，2013，25（3）：208-221.
[18] KUSHWAH R，OLIVER J R，ZHANG J，et aｌ. Apoptotic dendritic cells induce tolerance in mice through suppression of dendritic cell maturation and induction of antigen-specific regulatory T cells[J].J Immunol，2009，183 （11）：7104-7118.
[19] RICCARDI F，DELLA PORA M G，ROVATI B，et aｌ．Flow cytometric analysis of peripheral blood dendritic cells in patients with severe sepsis[J]. Cytometry B Clin Cytom，2011，80（1）：14-21.
[20] UNSINGER J，KAZAMA H，MCDONOUGH J S，et aｌ. Sepsis- induced apoptosis leads to active suppression of delayed-type hypersensitivity by CD8+ regulatory T cells through a TRAIL-dependent mechanism [J]. J Immunol，2010，184（12）：6766-6772.
[21] HONG Q，SANDERS R D， QING M D，et aｌ. Sedation improves early outcome in severely septic Sprague Dawley rats[J].Crit Care，2009，13（4）：R136.
[22] NING Q Q，LIU Z G，WANG X H，et aｌ. Neurodegenerative changes and neuroapoptosis induced by systemic lipopolysaccharide administration are reversed by dexmedetomidine treatment in mice[J]. Neurol Res，2017，39（4）：357-366.
[23] KANG K，GAO Y，WANG S C，et aｌ. Dexmedetomidine protects against lipopolysaccharide-induced sepsis-associated acute kidney injury via an α7nAChR -dependent pathway[J].Biomed Pharmacother，2018，106：210-216.
[24] CHANDHRY H，ZHOU J，ZHONG Y，et aｌ. Role of cytokines as a double edged sword in sepsis[J].In Vivo，2013，27（ 6）：669-684．
[25] CALVANO S E，XIAO W，RICHARDS D R，et aｌ. A network-based analysis of systemic inflammation in humans[J].Nature，2005，437（7061）：1032-1037.
[26] HOFER S，STEPPAN J，WAGNER T，et aｌ. Central sympatholytics prolong survival in experimental sepsis[J]. Crit Care，2009，13（1）：R11.
[27] ZABRODSKII P F，GROMOV M S，MASLYAKOV V V. Combined effect of NF-κB inhibitor and β2-adrenoreceptor agonist on mouse mortality and blood concentration of proinflammatory cytokines in sepsis[J].Bull Exp Biol Med，2018，165（4）：445-448.
[28] OHTA Y， MIYAMOTO K，KAWAZOE Y，et aｌ. Effect of dexmedetomidine on inflammation in patients with sepsis requiring mechanical ventilation：a sub-analysis of a multicenter randomized clinical trial[J].Crit Care，2020，24：493.
[29] WU Y Q，LIU Y C，HUANG H，et aｌ. Dexmedetomidine inhibits inflammatory reaction in lung tissues of septic rats by suppressing TLR4/ NF-κB pathway[J]. Mediators Inflamm，2013，2013：562154.
[30] ZHANG W Q，XU P，ZHAN X H，et aｌ. Efficacy of dexmedetomidine for treatment of patients with sepsis：a meta-analysis of randomized controlled trials[J].Medicine （Baltimore），2019，98（18）：e15469.
[31] YU K， KYOHEI M，TAKESHI M，et aｌ. Effect of dexmedetomidine on mortality and ventilator-free days in patients requiring mechanical ventilation with sepsis：a randomized clinical trial[J]. JAMA，2017，317（13）：1321-1328.
[32] NAKASHIMA T， MIYAMOTO K， SHIMA N，et aｌ. Dexmede tomidine improved renal function in patients with severe sepsis：an exploratory analysis of a randomized controlled trial[J]. J Intensive Care，2020，8：1.

相似文献/References:

[1]郭 峰,张 鹏.老年患者开胸术后急性呼吸衰竭不同治疗方案疗效比较[J].天津医科大学学报,2014,20(01):48.
　GUO Feng,ZHANG Peng.Comparative study on different treatments of postoperative acute respiratory failure by thoracotomy in elderly patients[J].Journal of Tianjin Medical University,2014,20(04):48.
[2]王 鹏.右美托咪定预处理对止血带性心肌损伤的保护作用[J].天津医科大学学报,2016,22(01):64.
[3]王 鹏,李庆丰,林 红,等.右美托咪定联合罗哌卡因局部浸润对鼻内镜手术后镇痛的影响[J].天津医科大学学报,2016,22(05):457.
[4]张婷婷,张广华.右美托咪定持续输注对结肠癌手术麻醉的影响[J].天津医科大学学报,2017,23(01):62.
[5]陈 鹏,王 鹏.超声引导胸椎旁神经阻滞用于非体外循环冠脉旁路移植术患者超前镇痛的效果[J].天津医科大学学报,2017,23(05):453.
[6]辛可可,庞锋,孙俊丽,等.适度液体负平衡在脓毒性休克机械通气患者撤机过程中的应用[J].天津医科大学学报,2018,24(02):148.
　XIN Ke -ke,PANG Feng,SUN Jun-li,et al.Application of moderate negative fluid balance in patients with septic shock during weaining from mechanical ventilation[J].Journal of Tianjin Medical University,2018,24(04):148.
[7]黄庆先,王鹏.右美托咪定对行肿瘤细胞减灭术联合术中腹腔热灌注化疗老年患者术后认知功能的影响[J].天津医科大学学报,2018,24(02):174.
[8]张文敬,房 怿,申 岱,等.全麻术中机械通气压力对心率变异性影响的临床研究[J].天津医科大学学报,2018,24(06):549.
[9]冯丽伟,赵 岳,王 斌,等.机械通气患者二次插管的影响因素分析[J].天津医科大学学报,2020,26(01):22.
　FENG Li-wei,ZHAO Yue,WANG Bin,et al.Analysis of influencing factors of secondary intubationin patients with mechanical ventilation[J].Journal of Tianjin Medical University,2020,26(04):22.
[10]齐颖,陈兵.盐酸右美托咪定对脓毒症急性肺损伤小鼠基质金属蛋白酶7抑制作用研究[J].天津医科大学学报,2022,28(01):65.
　QI Ying,CHEN Bing.Inhibitory effect of dexmedetomidine on serum matrix metalloproteinase 7 in mice with septic acute lung injury[J].Journal of Tianjin Medical University,2022,28(04):65.

备注/Memo

备注/Memo:

基金项目 国家自然科学基金面上项目（81970085）
作者简介:于乐昌（1987-），主治医师，硕士，研究方向：脓毒症免疫发病机制及其治疗策略相关研究；通信作者：张蔷，E-mail：zhangqiangyulv@163.com。

常用功能

更新日期/Last Update: 2022-07-20